In the early stages of bone metastasis, estrogen receptor (ER)-positive luminal cancers release signal peptide, CUB domain and EGF-like domain containing 2 (SCUBE2), which may help to induce osteoblasts to differentiate into osteoclasts, thereby inhibiting NK cells activity and providing favorable conditions for tumor colonization (57). This evidence concerns the gene ESR1 and cancer.